Cisplatin-Induced Apoptosis in Testicular Germ Cell Tumor Cell Lines
Author Information
Author(s): H Burger, K Nooter, AWM Boersma, CJ Kortland, G Stoter
Primary Institution: University Hospital Rotterdam and Rotterdam Cancer Institute
Hypothesis
Does the presence of wild-type p53 correlate with sensitivity to cisplatin-induced apoptosis in testicular germ cell tumor cell lines?
Conclusion
The study suggests that hypersensitivity to cisplatin-induced apoptosis in testicular germ cell tumor cell lines may not be directly correlated with the presence of wild-type p53 or the expression of Bcl-2 and Bax.
Supporting Evidence
- Three of four testicular germ cell tumor cell lines were hypersensitive to cisplatin-induced apoptosis.
- The resistant cell line 2102 EP showed minimal apoptosis even at high drug concentrations.
- Induction of apoptosis correlated with drug sensitivity in the MTT assay.
- Wild-type p53 was up-regulated in sensitive cell lines but not in resistant ones.
- Endogenous levels of Bcl-2 and Bax did not correlate with cisplatin-induced apoptosis.
Takeaway
Some testicular cancer cells are very sensitive to a drug called cisplatin, but having a specific protein called p53 doesn't always mean they will respond to the drug.
Methodology
The study examined four testicular germ cell tumor cell lines for their sensitivity to cisplatin-induced apoptosis and analyzed the expression of p53, Bcl-2, and Bax proteins.
Limitations
The study is limited to a small panel of cell lines and may not represent all testicular germ cell tumors.
Want to read the original?
Access the complete publication on the publisher's website